A novel interaction between hScrib and PP1γ downregulates ERK signaling and suppresses oncogene-induced cell transformation.
Previous studies have shown that the cell polarity regulator hScrib interacts with, and consequently controls, the ERK signaling pathway. This interaction occurs through two well-conserved Kinase Interacting Motifs, which allow hScrib to bind ERK1 directly, resulting in a reduction in the levels of...
Guardado en:
Autores principales: | Kazunori Nagasaka, Takayuki Seiki, Aki Yamashita, Paola Massimi, Vanitha Krishna Subbaiah, Miranda Thomas, Christian Kranjec, Kei Kawana, Shunsuke Nakagawa, Tetsu Yano, Yuji Taketani, Tomoyuki Fujii, Shiro Kozuma, Lawrence Banks |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45f0a6cc2a42441295e27e347cd5a114 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
por: Raphael Brandt, et al.
Publicado: (2019) -
Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells.
por: Brady G Strittmatter, et al.
Publicado: (2021) -
Oncogene
Publicado: (1987) -
Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
por: Pamela A. Lochhead, et al.
Publicado: (2020) -
ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy.
por: Clara I Aceves-Luquero, et al.
Publicado: (2009)